News
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor ...
Macquarie described Neuren Pharmaceuticals shares as a standout in the biotech industry and set a price target of $18.60 on ...
Are Brickworks Ltd (ASX: BKW) or Reliance Worldwide Corporation Ltd (ASX: RWC) shares the better buy? Let's find ...
In morning trade, the ASX 200 uranium stock is up 2% to $4.57. This leaves it just short of its 52-week high of $4.63.
This ASX 300 stock is having a good session on Wednesday. Let's see why investors are bidding its shares higher ...
Analysts from Morgan Stanley believe the humanoid robot market could be worth $5 trillion by 2035. Musk believes Tesla could ...
These 2 ASX growth shares could deliver big returns, in my opinion. Here’s why I’m excited about them right now.
Aurizon Holdings has struck a new deal with materials giant BHP. Macquarie believes this is good news for Aurizon shares.
Citi currently has a buy rating and $2.70 price target on its shares. Another ASX dividend stock that has been given a buy ...
The ASX dividend share is one of the leaders in the sector, in my opinion. It's expecting to pay a distribution per security ...
Macquarie has released a new note on Cochlear Ltd (ASX: COH) shares following the company's FY25 profit guidance change.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results